|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 471/08 | (2006.01) |
| A61K 31/439 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Patento numeris | 2834239 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13715426.6 |
| Europos patento paraiškos padavimo data | 2013-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-02-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-27 |
| (46) | Apibrėžties vertimo paskelbimo data | 2018-03-26 |
| (86) | Numeris | PCT/GB2013/050869 |
| Data | 2013-04-02 |
| (87) | Numeris | WO 2013/150296 |
| Data | 2013-10-10 |
| (30) | Numeris | Data | Šalis |
| 201261618993 P | 2012-04-02 | US |
| (72) |
MCGUIRE, Helen, US
BIST, Shanta, US
BIFULCO, Neil, US
ZHAO, Liang, US
WU, Ye, US
HUYNH, Hoan, US
XIONG, Hui, US
COMITA-PREVOIR, Janelle, US
DUSSAULT, Daemian, US
GENG, Bolin, US
CHEN, Brendan, US
DURAND-REVILLE, Thomas, US
GULER, Satenig, US
|
| (73) |
Entasis Therapeutics Limited,
2 Kingdom Street, London W2 6BD,
GB
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Heterobicikliniai junginiai kaip beta-laktamazės inhibitoriai |
| HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-03-18 | 13 | 289.00 EUR |
| 2026-04-02 |